Advertisement

Aging Clinical and Experimental Research

, Volume 26, Issue 1, pp 47–51 | Cite as

Prevalence of vitamin D insufficiency among community dwelling elderly in Dakahlia as a representative of rural areas in Egypt

  • Walaa W. AlyEmail author
  • Mona A. Hussein
  • Somaia Moahamed. Ebeid
  • Ahmed K. Mortagy
Original Paper

Abstract

Background

Vitamin D has a basic role in bone growth and metabolism and has been noticed for its important role in many diseases.

Objectives

To detect the prevalence of vitamin D insufficiency among the elderly in Dakahlia.

Methodology

A cross-sectional study was conducted on 176 elderly patients (60 years and older) recruited from Meet Abbad-Nabaroh-Dakahlia, Egypt. The level of 25 hydroxy vitamin D (25OHD) was measured. A normal level of vitamin D is defined as a 25OHD concentration ≥30 ng/mL. Vitamin D insufficiency is defined as a 25OHD concentration of 20–29 ng/mL. Vitamin D deficiency is defined as a 25OHD level <20 ng/mL.

Results

There were no cases of vitamin D deficiency among the studied population. The prevalence of vitamin D insufficiency (25OHD level of 20–29 ng/mL) among the elderly in Dakahlia was 26 %. Prevalence of vitamin D insufficiency was (37.9 %) in males and (15.3 %) in females.

Conclusion

There was a low prevalence of vitamin D insufficiency in an elderly rural population and a higher prevalence of vitamin D insufficiency among males than females.

Keywords

Prevalence Vitamin D insufficiency Elderly 

Notes

Conflict of interest

The authors had no conflicts of interest of any kind.

References

  1. 1.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Garland CF, Gorham ED, Mohr SB, Garland FC (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19:468–483PubMedCrossRefGoogle Scholar
  3. 3.
    Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60–65PubMedCrossRefGoogle Scholar
  4. 4.
    Holick MF (2010) Vitamin D: extraskeletal health. Endocrinol Metab Clin N Am 39:381–400CrossRefGoogle Scholar
  5. 5.
    Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511PubMedCrossRefGoogle Scholar
  6. 6.
    Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S et al (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134:1129–1140PubMedCrossRefGoogle Scholar
  7. 7.
    Lips P (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89–90:611–614Google Scholar
  8. 8.
    Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443PubMedCrossRefGoogle Scholar
  9. 9.
    IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DCGoogle Scholar
  10. 10.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281PubMedCrossRefGoogle Scholar
  11. 11.
    Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90:4119–4123PubMedCrossRefGoogle Scholar
  12. 12.
    Lips P, Hosking D, Lippuner K et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260:245–254PubMedCrossRefGoogle Scholar
  13. 13.
    Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M et al (2006) The status of biochemical parameters in varying degrees of vitamin D deficiency. J Bone Miner Metab 24:213–218PubMedCrossRefGoogle Scholar
  14. 14.
    Mirsaeid Ghazi AA, Rais Zadeh F, Pezeshk P, Azizi F (2004) Seasonal variation of serum-hydroxy D3 in residents of Tehran. J Endocrinol Invest 27:676–679Google Scholar
  15. 15.
    Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel MJ et al (1996) Lower serum 25- hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: A population-based study. Exp Clin Endocrinol Diabetes 104:289–292PubMedCrossRefGoogle Scholar
  16. 16.
    Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA (2008) Serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr 88:1519–1527PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Brot C, Jorgensen NR, Sorensen OH (2001) The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 53:920–926CrossRefGoogle Scholar
  18. 18.
    Kiel DP, Zhang Y, Hannan MT, Anderson JJ, Baron JA, Felson DT (1996) The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos Int 6:240–248PubMedCrossRefGoogle Scholar
  19. 19.
    Chel VG, Ooms ME, Pavel S, De Gruijl F, Brand A, Lips P (2001) Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study. Age Ageing 40:211–214CrossRefGoogle Scholar
  20. 20.
    Holick MF (2002) Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9:87–98CrossRefGoogle Scholar
  21. 21.
    Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 77:13–42Google Scholar
  22. 22.
    Van der Wielen RPJ, Löwik MRH, van der Berg H, de Groot LC, Haller J, Moreiras O et al (2006) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207–210CrossRefGoogle Scholar
  23. 23.
    Ovesen L, Brot C, Jakobsen J (2003) Food contents and biological activity of 25-hydroxyvitamin D. A vitamin D metabolite to be reckoned with? Ann Nutr Metab 47:107–113PubMedCrossRefGoogle Scholar
  24. 24.
    Petta S, Cammà C, Scazzone C et al (2010) Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 51:1158–1167PubMedCrossRefGoogle Scholar
  25. 25.
    Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28:1228–1230PubMedCrossRefGoogle Scholar
  26. 26.
    Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820–825PubMedGoogle Scholar
  27. 27.
    Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063–1069PubMedCrossRefGoogle Scholar
  28. 28.
    McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B et al (1996) Relation of dietary intake of serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med 125:353–359PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  • Walaa W. Aly
    • 1
    Email author
  • Mona A. Hussein
    • 1
  • Somaia Moahamed. Ebeid
    • 1
  • Ahmed K. Mortagy
    • 1
  1. 1.Department of Geriatrics and GerontologyAin Shams University Hospitals, Ain Shams UniversityCairoEgypt

Personalised recommendations